000425573 000__ 01659cam\a2200421\a\4500
000425573 001__ 425573
000425573 005__ 20220217103419.0
000425573 008__ 061016s2006\\\\dcu\\\\\\\\\\f000\0\eng\c
000425573 035__ $$a(OCoLC)ocm73146677
000425573 035__ $$a(OCoLC)73146677
000425573 035__ $$a425573
000425573 040__ $$aGPO$$cGPO$$dGPO
000425573 042__ $$apcc
000425573 043__ $$an-us---
000425573 049__ $$aISEA
000425573 05014 $$aKF32$$b.E55 2006p
000425573 074__ $$a1008-C
000425573 074__ $$a1008-C (online)
000425573 074__ $$a1008-D (MF)
000425573 074__ $$a1008-D (online)
000425573 0860_ $$aY 1.1/8:109-686
000425573 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Energy and Commerce.
000425573 24510 $$aBiodefense and Pandemic Vaccine and Drug Development Act of 2006 :$$breport (to accompany H.R. 5533) (including cost estimate of the Congressional Budget Office).
000425573 260__ $$a[Washington, D.C. :$$bU.S. G.P.O.,$$c2006]
000425573 300__ $$a26 p. ;$$c24 cm.
000425573 4901_ $$aReport / 109th Congress, 2d session, House of Representatives ;$$v109-686
000425573 500__ $$aCaption title.
000425573 500__ $$aDistributed to some depository libraries in microfiche.
000425573 500__ $$aShipping list no.: 2007-0019-P.
000425573 500__ $$a"September 26, 2006."
000425573 650_0 $$aDisaster medicine$$xLaw and legislation$$zUnited States.
000425573 650_0 $$aVaccines$$xLaw and legislation$$zUnited States.
000425573 650_0 $$aAntitoxins$$xLaw and legislation$$zUnited States.
000425573 650_0 $$aDrugs$$xLaw and legislation$$zUnited States.
000425573 650_0 $$aMedicine$$xResearch$$xLaw and legislation$$zUnited States.
000425573 8101_ $$aUnited States.$$bCongress.$$bHouse.$$tReport ;$$v109-686.
000425573 85230 $$bdfich$$hY 1.1/8:$$i109-686
000425573 85641 $$3Text version$$uhttp://purl.access.gpo.gov/GPO/LPS74892
000425573 85641 $$3PDF version$$uhttp://purl.access.gpo.gov/GPO/LPS74893
000425573 909CO $$ooai:library.usi.edu:425573$$pGLOBAL_SET
000425573 980__ $$aBIB
000425573 980__ $$aGOV RESOURCE